Strategy&

strategy, made real.

New York, NY, United States

Strategy subsidiary of PwC that partners with health tech companies like Luca Healthcare to build digital health solutions for life sciences companies.

Shareable draft

Check out Strategy& on @MedStartr Today Strategy subsidiary of PwC that partners with health tech companies like Luca Healthcare to build digital health solutions for life sciences companies. #Longevity #Wellness #PrecisionMedicine #DiseasePrevention #HealthcareInfrastructure #MedMo #MedStartrVentures

https://www.medstartr.ai/s/m7DZ33AkhAE

Get Involved in Strategy&

How We Help

Problem Statement

Strategy& helps clients navigate complex strategic challenges and transform their businesses within the evolving healthcare landscape, addressing needs from business model development and market analysis to policy shaping and operational optimization.

Key Differentiators

["Integrates strategic thinking with PwC's extensive implementation capabilities.", "Operates under the philosophy of 'strategy, made real'.", "Combines deep industry knowledge with extensive functional expertise.", "Active research and advice on the evolving healthcare landscape, focusing on prevention, longevity, and wellness ('LIFEcare').", "Expertise in leveraging AI and GenAI in medical affairs and precision medicine."]

Clinical Focus

Strategy and consulting services for healthcare facilities, government entities, payors, hospitals, health systems, and life sciences companies, focusing on areas like digital strategy, value-based care, operational optimization, prevention, longevity, wellness, precision medicine, and the application of AI/GenAI in medical affairs.

Target Customers

Healthcare facilities (hospitals, clinics, diagnostic laboratories, imaging centers), Government entities, Payors, Hospitals, Health systems, Life sciences companies (pharmaceutical, biotech, medical devices, diagnostics companies)

Company Info

Business Model: B2B
Founded: 2014

Disease Areas

Longevity Wellness Precision Medicine Disease Prevention

Technologies

Specialized SoftwareGenAICloud ComputingAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

PwC Strategy& backs advisory with evidence-based healthcare research and case studies. The firm partners on large-scale quality improvement programs and clinical integration projects with major health systems, validated through published healthcare outcomes research.

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Strategy&?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.